These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6471204)
1. Correlation between stage and grade in prostatic adenocarcinoma: a morphometric study. Sharkey FE; Dusenbery DM; Moyer JE; Barry JD J Urol; 1984 Sep; 132(3):602-5. PubMed ID: 6471204 [TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
3. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. Partin AW; Epstein JI; Cho KR; Gittelsohn AM; Walsh PC J Urol; 1989 Feb; 141(2):341-5. PubMed ID: 2913356 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. Lee SE; Currin SM; Paulson DF; Walther PJ J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Zagars GK; von Eschenbach AC; Ayala AG Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659 [TBL] [Abstract][Full Text] [Related]
6. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. Cantrell BB; DeKlerk DP; Eggleston JC; Boitnott JK; Walsh PC J Urol; 1981 Apr; 125(4):516-20. PubMed ID: 7218450 [TBL] [Abstract][Full Text] [Related]
7. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival. Fowler JE; Mills SE J Urol; 1985 Jan; 133(1):49-52. PubMed ID: 3964879 [TBL] [Abstract][Full Text] [Related]
8. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status. Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934 [TBL] [Abstract][Full Text] [Related]
9. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. Epstein JI; Oesterling JE; Walsh PC J Urol; 1988 May; 139(5):980-4. PubMed ID: 3361676 [TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229 [TBL] [Abstract][Full Text] [Related]
11. Prognostic parameters in radiotherapeutic management of localized carcinoma of the prostate. Pilepich MV; Perez CA; Bauer W J Urol; 1980 Oct; 124(4):485-7. PubMed ID: 7420590 [TBL] [Abstract][Full Text] [Related]
12. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. Epstein JI; Carmichael M; Partin AW; Walsh PC J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792 [TBL] [Abstract][Full Text] [Related]
13. Aid to accurate clinical staging-histopathologic grading in prostatic cancer. Thomas R; Lewis RW; Sarma DP; Coker GB; Rao MK; Roberts JA J Urol; 1982 Oct; 128(4):726-8. PubMed ID: 7143593 [TBL] [Abstract][Full Text] [Related]
14. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. Epstein JI; Paull G; Eggleston JC; Walsh PC J Urol; 1986 Oct; 136(4):837-9. PubMed ID: 3761442 [TBL] [Abstract][Full Text] [Related]
15. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival. Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989 [TBL] [Abstract][Full Text] [Related]
16. The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Zagars GK; Ayala AG; von Eschenbach AC; Pollack A Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):237-45. PubMed ID: 7836075 [TBL] [Abstract][Full Text] [Related]
17. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading]. Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593 [TBL] [Abstract][Full Text] [Related]
18. Incidental carcinoma of the prostate: significance of staging transurethral resection. Carroll PR; Leitner TC; Yen TS; Watson RA; Williams RD J Urol; 1985 May; 133(5):811-4. PubMed ID: 3989921 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. Benson MC; Kaplan SA; Olsson CA J Urol; 1987 May; 137(5):888-90. PubMed ID: 3573183 [TBL] [Abstract][Full Text] [Related]
20. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors. Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]